Heterogeneity of bcl-2 expression in MALT lymphoma.
Bcl-2 protein expression was studied in a series of 58 MALT lymphomas using a monoclonal antibody which recognises this protein in routinely processed paraffin embedded tissue. Thirty-three of 58 cases showed heterogeneity for bcl-2 expression, 18 of 58 cases were bcl-2 positive and 7 of 58 were bcl-2 negative. High grade and low grade MALT lymphomas showed different patterns of staining. All 21 low grade tumours were positive for bcl-2, though in seven cases only a proportion of the neoplastic cells expressed this protein. In the 37 high grade tumours the majority of the neoplastic cells were negative with seven cases showing no reactivity at all. These findings give further support to the theory that MALT lymphomas differ in pathogenesis to nodal lymphomas and suggest that the good prognosis of MALT lymphomas may partly be explained by the fact that they maintain a normal pattern of bcl-2 expression.
Ashton-Key
M
M
Department of Cellular Pathology, John Radcliffe Hospital, Oxford, UK.
Biddolph
S C
SC
Stein
H
H
Gatter
K C
KC
Mason
D Y
DY
D005770:Gastrointestinal Neoplasms / Q000737:chemistry; D006801:Humans; D007124:Immunoenzyme Techniques; D018442:Lymphoma, B-Cell, Marginal Zone / Q000737:chemistry*; D011518:Proto-Oncogene Proteins / Q000032:analysis*; D019253:Proto-Oncogene Proteins c-bcl-2; D012468:Salivary Gland Neoplasms / Q000737:chemistry; D013964:Thyroid Neoplasms / Q000737:chemistry
D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2